BactiQuant AS (OCSE:BACTIQ) Altman Z2-Score: 4.93 (As of Jul. 01, 2026) — 14% Below Median


OCSE:BACTIQ BactiQuant AS OCSE:BACTIQ
56 GF Score
Price kr2.50
GF Value kr2.36
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is BactiQuant AS Altman Z2-Score?

BactiQuant AS OCSE:BACTIQ -3.85% 56 Altman Z2-Score is 4.93 as of Jul. 01, 2026, which is 14% below its 10-year median of 5.70. GuruFocus rates OCSE:BACTIQ with a GF Score™ of 56/100 and a GF Value™ of kr2.36 (Fairly Valued). The stock has 4 warning signs investors should review. Among 3,037 Industrial Products companies, BactiQuant AS ranks better than 57.89% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

BactiQuant AS has a Altman Z2-Score of 4.93, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for BactiQuant AS's Altman Z2-Score or its related term are showing as below:

OCSE:BACTIQ' s Altman Z2-Score Range Over the Past 10 Years
Min: -4.52   Med: 5.7   Max: 9.08
Current: 4.93

During the past 8 years, BactiQuant AS's highest Altman Z2-Score was 9.08. The lowest was -4.52. And the median was 5.70.


BactiQuant AS  (OCSE:BACTIQ) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


BactiQuant AS Altman Z2-Score Related Terms


BactiQuant AS Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for BactiQuant AS's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BactiQuant AS Altman Z2-Score Chart

BactiQuant AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z2-Score
Get a 7-Day Free Trial 9.08 2.57 3.77 -4.52 4.93

BactiQuant AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.77 0.00 -4.52 0.00 4.93

OCSE:BACTIQ vs VLTO, ZWS, CECO: Altman Z2-Score Comparison

For the Pollution & Treatment Controls subindustry, BactiQuant AS's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BactiQuant AS Altman Z2-Score vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, BactiQuant AS's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where BactiQuant AS's Altman Z2-Score falls into.


OCSE:BACTIQ
56GF Score
BactiQuant AS OCSE:BACTIQ
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BactiQuant AS Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

BactiQuant AS's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.6994+3.26*0.5011+6.72*-0.4418+1.05*1.5971
=4.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was kr28.07 Mil.
Total Current Assets was kr23.54 Mil.
Total Current Liabilities was kr3.91 Mil.
Retained Earnings was kr14.06 Mil.
Pre-Tax Income was kr-13.83 Mil.
Interest Expense was kr-1.43 Mil.
Total Liabilities was kr10.81 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(23.541 - 3.911)/28.068
=0.6994

X2=Retained Earnings/Total Assets
=14.064/28.068
=0.5011

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-13.833 - -1.433)/28.068
=-0.4418

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(17.261 - 0)/10.808
=1.5971

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

BactiQuant AS has a Altman Z2-Score of 4.93 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 4.93 mean?
BactiQuant AS (OCSE:BACTIQ) has a Altman Z2-Score of 4.93 as of Jul. 01, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on BactiQuant AS and its competitors. This is 14% below median its historical median of 5.70. According to the industry distribution chart, BactiQuant AS ranks #1279 out of 3037 companies in the Industrial Products industry, placing it in the top 42.1%.
Is BactiQuant AS's Altman Z2-Score too high?
BactiQuant AS's current Altman Z2-Score of 4.93 is 14% below median its 10-year median of 5.70. The Industrial Products industry median Altman Z2-Score is 4.28. BactiQuant AS's value of 4.93 is 15.2% above this industry median. Based on the distribution chart, BactiQuant AS ranks #1279 out of 3037 companies in the Industrial Products industry, which is above the industry midpoint. Overall, BactiQuant AS has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BactiQuant AS's Altman Z2-Score compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, BactiQuant AS ranks #1279 out of 3037 companies for Altman Z2-Score. This puts BactiQuant AS in the upper half of its industry. The industry median Altman Z2-Score is 4.28. BactiQuant AS's value of 4.93 is 15.2% above this benchmark. While the company's 10-year median is 5.70 vs. the industry median of 4.28, BactiQuant AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for an Industrial Products company?
The median Altman Z2-Score among Industrial Products companies is 4.28, based on 3,037 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BactiQuant AS's current Altman Z2-Score of 4.93 is 15.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on BactiQuant AS and its competitors. For the Industrial Products industry, the median Altman Z2-Score is 4.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BactiQuant AS's current Altman Z2-Score is 4.93, which is 14% below median its own 10-year median of 5.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BactiQuant AS stock overvalued right now?
Based on GuruFocus' analysis, BactiQuant AS (OCSE:BACTIQ) is currently considered Fairly Valued. The stock's GF Value™ is kr2.36, compared to a current price of kr2.50 — trading 5.9% above its estimated fair value. The current Altman Z2-Score is 4.93, which is 14% below median its 10-year median of 5.70 and 15.2% above the Industrial Products industry median of 4.28. BactiQuant AS's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For BactiQuant AS (OCSE:BACTIQ), the current Altman Z2-Score is 4.93 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BactiQuant AS (OCSE:BACTIQ) Overvalued in 2026?

Based on GuruFocus' analysis, BactiQuant AS stock appears to be overvalued. The current stock price of kr2.50 is trading 5.9% above its estimated GF Value™ of kr2.36. GuruFocus considers BactiQuant AS to be Fairly Valued.

Key valuation signals for OCSE:BACTIQ:

  • Altman Z2-Score: 4.93 (14% below median its 10-year median of 5.70)
  • GF Value™: kr2.36 vs. price of kr2.50 (5.9% above fair value)
  • GF Score™: 56/100 with 4 warning signs
  • Industry Position: 15.2% above the Industrial Products median (#1279 of 3037)

No single metric tells the full story. See the OCSE:BACTIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BactiQuant AS Business Description

Address Blokken 75, Birkeroed, DNK, DK-3460
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
56GF Score

Get the complete analysis for OCSE:BACTIQ

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.50
Price
kr2.36
GF Value